SSWM
ARNA

Sheets Smith Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sheets Smith Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,408
Closed -$89K – 284
2014
Q1 		$89K Hold
1,408
– – 0.02% 243
2013
Q4 		$82K Buy
+1,408
New +$73.6K 0.02% 259

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sheets Smith Wealth Management's ARNA Position: Q2 2014 in Review

Sheets Smith Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 1,408 shares — an estimated $89K sold.

Sheets Smith Wealth Management first reported a position in ARNA in Q4 2013 and held it in 2 quarters. The position peaked at $89K in Q1 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

  • Sheets Smith Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 1,408 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $89K.
  • Sheets Smith Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 2 quarters.
  • Sheets Smith Wealth Management's Arena Pharmaceuticals Inc position peaked at $89K in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2014, filed 18 Sep 2014.